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Goals: This study was undertaken to investigate the relationship 
between serum leptin levels and the development irritable bowel 
syndrome (IBS). 
Background: Stress has been known as an important causative 
factor in IBS. Various studies have indicated the relationship 
between serum leptin levels and stress levels. So searching the 
relationship between the production and level of this hormone and 
development of IBS may help to understand the pathophysiology 
of the disease. 
Study: This was a case-control study. Eighty IBS patient and 80 
controls were recruited. All participants were asked to ﬁll in a 
questionnaire included demographic information and medical 
history and also a stress questionnaire. Serum leptin level was 
measured by enzyme-linked immunosorbent assay method. Chi-
square, Student t test, Pearson correlation and logistic regression 
were used for investigating the relationships between variables. 
Results: Mean serum leptin levels were 7.41 and 19.33 ng/mL in IBS 
and control groups, respectively (P<0.001). Participants in IBS 
group had signiﬁcantly higher stress levels than controls 
(P<0.001). Multivariate logistic regression analysis showed that 
adjusted odds ratios (ORs) for serum leptin level (OR: 0.9; 95% 
conﬁdence interval: 0.85-0.94) and stress level (OR: 1.15; 95% 
conﬁdence interval: 1.09-1.23) were nearly the same as crude ones. 
Conclusions: This study indicated the relationship between leptin 
and IBS for the ﬁrst time. Our results show that serum leptin level 
is signiﬁcantly lower in IBS group than controls and this 
relationship is independent of other variables such as stress levels, 
body mass index, etc. This may help in better understanding of the 
pathogenesis of IBS and consequently lead to the development of 
more eﬀective treatments. 
Key Words: irritable bowel syndrome, leptin, stress 
(J Clin Gastroenterol 2009;43:826–830) 
Irritable bowel syndrome (IBS) is a functional disorder of gastrointestinal system,1 characterized by altered bowel 
habits and abdominal pain in the absence of detectable 
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structural abnormalities.2 Prevalence of IBS is 10% to 20% 
all over the world, 70% with present mild manifestations of 
the disease, 25% and 5% present on moderate and severe 
types, respectively.2,3 The disease is more common in 
developed countries but its prevalence is increasing in 
developing world.4 In the United States, 8 billion dollars is 
spent for this disease annually. IBS is diagnosed by ROME 
II criteria.2 One may develop the disease on any period of 
life, for example, similar manifestations have been detected 
in children but investigating therapeutic methods in adults 
has some priority in research topics. According to recent 
research, women are more predisposing to IBS than men.3 
Unfortunately, despite having high prevalence and so 
many social and economic complications, the etiology and 
pathogenesis of the disease has not been clearly known.5–7 
Psychologic stress,8 female sex,2,9 young ages,2 abuse 
(physical and psychologic), neonatal maternal deprivation, 
neonatal colonic irritation (inﬂammatory stimuli), neonatal 
colonic pain (rectal distension),10 Blastocystis hominis,11 
dysbiotic changes in the large and small intestines after 
enteric infections,12 trauma,5 and heredity13 have been 
proposed as some probable etiologic factors of IBS. 
The interface of psychiatry (anxiety disorders, depres­
sive disorders, and somatoform disorders) and IBS has 
been well established,9 with psychiatric comorbidity 
approaching 20% to 60%.5 Stress is an important causative 
factor in IBS.14 It remains unknown whether stress-related 
changes in gut function are mediated by altered autonomic 
eﬀerent gut-speciﬁc innervation.14 Patients with IBS show 
heightened visceral sensation, suggesting involvement of 
a diﬀerent regulatory mechanism, either central or peri­
pheral.14 
Various studies have indicated that by increasing 
catecholamine and stress, serum leptin level changes 
signiﬁcantly.15,16 So, searching the relationship between 
the production and level of this hormone and development 
of IBS may help to understand the pathophysiology of the 
disease. Leptin (derived from Greek word leptus that means 
thin) is a peptide hormone and was discovered in 1994 
for the ﬁrst time.15 This hormone weights 16 kd and is 
produced by obesity gene. Obesity gene is expressed in 
white fat, placenta, etc. It was known as modulator of 
receiving and consuming energy, and controlling body 
weight. Its function depends on its receptors in feeding 
center of hypothalamus.16 Recent studies have indicated 
that leptin has various eﬀects on other organs and body 
systems too; these include immune system, gynecology 
system, gastrointestinal system and specially central ner­
vous system, and peripheral nervous system. Recently, 
leptin expression has been detected in gastric epithelium, 
but the physiologic role of gastric leptin remains un­
known.17 
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With regard to the above information, the theory of 
relationship between leptin and IBS can be oﬀered. So, this 
study was undertaken to investigate this relationship for the 
ﬁrst time. 
MATERIALS AND METHODS 
This was a case-control study. The study population 
was consisted on patients who were referred to gastro­
enterology clinic of 5th Azar Hospital (Gorgan, Iran) 
during period 2005 to 2006 and presented with symptoms 
compatible with IBS based on ROME II criteria,2 identiﬁed 
by gastroenterologists (after exclusion of any disease 
proposed as diﬀerential diagnoses of IBS). Eighty of these 
patients were selected randomly. A consent form was taken 
and they were referred to Golestan Research Center of 
Gastroenterology and Hepatology. In this center, the study 
was explained to them and they were asked to ﬁll in 
questionnaire included demographic information, medical 
history, and some selected clinical manifestations. Eighty 
healthy controls were selected from individuals who 
referred to optometric clinic of 5th Azar Hospital. Controls 
had no history of gastrointestinal disorders and in clinical 
examination done by a gastroenterologist; they were free of 
any gastrointestinal signs and symptoms. A consent form 
was taken again and they were also asked to ﬁll in the 
questionnaire. Individuals with chronic diseases (diabetes 
mellitus, hypertension, asthma, renal and hepatic failure, 
history of gastrointestinal surgery, anorexia, psychiatric 
problems treated by antipsychotic drugs) and also pregnant 
and breast feeding women were excluded from both case 
and control groups. With regard to confounding eﬀect of 
stress in the relationship between leptin level and IBS, stress 
levels were evaluated in case and control groups by 
standard perceived stress scale 10 (Perceived Stress Scale 
10) questionnaire.18 It includes 10 questions which are of 
a general nature and hence are relatively free of content 
speciﬁc to any subpopulation group. It has been translated 
into Persian and the reliability of the translated version was 
evaluated by test retest method during a pilot study 
(k = 0.76). In the next step, 5 cm3 of (8 h) fasting blood 
sample was taken from the case and control groups in 
morning. Serum samples were preserved in - 701C till the 
time of processing. Leptin level was measured by enzyme-
linked immunosorbent assay methods using Biovendor 
leptin kit (Czech Republic). Data were entered into the 
computer and were analyzed by SPSS13 software. Chi-
square, Student t test, Pearson correlation, and logistic 
regression were used for investigating the relationship 
between variables. P values of less than 0.05 were 
considered as signiﬁcant. This project was approved by 
ethics committee of Golestan University of Medical 
Sciences. 
RESULTS 
Eighty IBS cases with mean ± SD age of 31.83 ± 
10.89 years and 80 controls with a mean ± SD age of 
32.38 ± 13.55 years participated in our study. Participants 
in IBS group had alternate constipation and diarrhea type 
IBS. The severity of IBS in almost all of them was 
moderate. The characteristics of participants and the 
comparison between 2 groups are shown in Table 1. No 
signiﬁcant relationship was found among the distribution 
of age, body mss index (BMI), sex, education level, and 
marital status between IBS and control groups (Table 1). 
TABLE 1. Sociodemographic Properties of IBS Patients and 
Controls 
IBS Control 
Variables Group Group P 
Mean of age (y) 31.83 32.38 0.78* 
Mean of BMI (kg/m2) 25.1 25 0.89* 
Sex 
Male 42.5% 38.8% 0.75w 
Female 57.5% 61.2% 
Education 
High 63.8% 70.9% 0.4w 
Low 36.2% 29.1% 
Marital status 
Married 68.8% 75% 0.48w 
Single 31.2% 25% 
Mean of stress level 21.74 15.31 <0.001* 
(PSS scores) 
Mean of serum leptin 7.41 19.33 <0.001* 
levels (ng/mL) 
*Student t test. 
ww2 test. 
BMI indicates body mass index; IBS, irritable bowel syndrome; PSS, 
Perceived Stress Scale. 
Participants in IBS group had signiﬁcantly higher stress 
levels than controls (P<0.001) (Table 1). In the other 
hand, serum leptin levels were signiﬁcantly lower in IBS 
group than the other one (P<0.001) (Table 1). The normal 
range for serum leptin in our laboratory was 13.48 to 
19.67 ng/mL. The mean of serum leptin level in controls 
was within normal range. But in IBS cases it was lower than 
normal. Overall, there was a signiﬁcant negative correlation 
between serum leptin levels and stress levels in all 
participants (r = - 0.17, P = 0.03); but it was not sig­
niﬁcant separately within each of the 2 groups. Table 2 
shows the relationship between serum leptin and other 
variables separately in IBS and control groups. In both 
groups, serum leptin levels were signiﬁcantly higher in 
TABLE 2. Relationship Between Serum Leptin and Other 
Variables Separately in IBS and Control Groups 
IBS Group Control Group 
Mean±SD Mean±SD of 
of Leptin Leptin Level 
Variables Level (ng/mL) P* (ng/mL) P* 
Sex 
Male 3.92±3.1 <0.001 14.57±11.82 0.04 
Female 10 ± 7.6 22.34 ± 17.32 
Education 
High 8.04 ± 6.99 0.27 18.75 ± 15.80 0.71 
Low 6.31 ± 6.39 20.21 ± 16.25 
Marital status 
Married 6.14 ± 5.38 0.26 25.05 ± 18.39 0.06 
Single 7.99 ± 7.31 17.42 ± 14.51 
BMI (kg/m2) 
r24.5(Normal/ 5.03 ± 5.04 0.002 21.11 ± 16.14 0.4 
underweight) 
>24.5(Over- 9.57 ± 7.48 18.08 ± 15.61 
weight/obese) 
*Student t test.
 
BMI indicates body mass index; IBS, irritable bowel syndrome.
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TABLE 3. Relationship Between Stress Levels (Mean of PSS 
Scores) and Other Variables Separately in IBS and Control Groups 
IBS Group Control Group 
Mean ± SD of Mean ± SD of 
Variables Stress Levels P* Stress Levels P* 
Sex 
Male 20.35 ± 7.5 0.12 12.35 ± 5.1 0.001 
Female 22.76 ± 5.7 17.18 ± 6.8 
Education 
High 21 ± 7.1 0.16 16.14 ± 6.8 0.1 
Low 23.03 ± 5.5 13.43 ± 6.1 
Marital status 
Married 21.62 ± 6.8 0.81 14.93 ± 6.6 0.38 
Single 22 ± 6.3 16.45 ± 6.8 
BMI (kg/m2) 
r24.5 22.05 ± 6.9 0.69 17.09 ± 6.5 0.04 
(Normal) 
>24.5 21.45 ± 6.4 14.06 ± 6.5 
(Overweight/ 
obese) 
*Student t test.
 
BMI indicates body mass index; IBS, irritable bowel syndrome.
 
females than males. Serum leptin level was not signiﬁcantly 
related with education level and marital status in the 2 
groups. In IBS group, serum leptin level had a signiﬁcant 
positive correlation with BMI (r = 0.37; P = 0.001) but the 
association between these variables in control group was 
not signiﬁcant (r = - 0.1; P = 0.34). Relationships be­
tween stress levels and other variables separately in IBS and 
control groups are shown in Table 3. Females had more 
stress than males in both groups, although the diﬀerence 
was not signiﬁcant in IBS group. No signiﬁcant relationship 
was found between stress levels and education, and marital 
status in IBS and control groups. Individuals with normal 
weight (BMI r24.5 kg/m2) had higher stress levels in both 
cases and control groups, but the relationship was not 
signiﬁcant in ﬁrst one. We used multivariate logistic 
regression analysis to assess if BMI and stress levels had 
any confounding eﬀects on the relationship between serum 
leptin levels and IBS. BMI was excluded from the model 
because of nonsigniﬁcant relationship. Adjusted odds ratios 
for serum leptin level and stress level were nearly the same 
as crude ones (Table 4). 
DISCUSSION 
IBS is one of the most common gastrointestinal 
disorders, characterized by abdominal pain and disturbed 
defecation that cannot be explained by structural abnorm­
alities.10 Although IBS symptoms (visceral pain, increased 
gut permeability, motility alterations)10 have been clearly 
known, the etiology has been poorly understood. We 
conducted this study to determine the relationship between 
serum leptin levels and IBS. 
We did not ﬁnd signiﬁcant diﬀerences in age, sex, 
BMI, education level, and marital status between IBS 
and control groups (Table 1). So, we can exclude the 
confounding eﬀects of these variables on the relationship 
between serum leptin levels and the development of IBS. 
Stress levels in IBS group were signiﬁcantly more than 
controls. Other studies suggested similar ﬁndings.5,14 Serum 
leptin levels were signiﬁcantly lower in IBS than the other 
group. Unfortunately, we did not ﬁnd any similar study in 
the literature review. 
Overall, there was a signiﬁcant negative correlation 
between serum leptin levels and stress levels in all 
participants. Results from 1 study also showed a reduction 
in leptin plasma levels during academic stress as compared 
with baseline. It seems that stress exerts a negative feedback 
mechanism over leptin production.19,20 
In both groups, serum leptin levels were signiﬁcantly 
higher in females than males. This was in agreement with 
other studies indicated that women had higher baseline 
endogenous leptin levels than men and that the slope of the 
correlation between serum leptin concentration and BMI 
was steeper in women.15,21–26 
In IBS group, serum leptin levels were signiﬁcantly 
higher in overweight/obese individuals than normal/under­
weight ones (Table 2). Previous studies showed signiﬁcant 
positive correlation between individuals BMI and serum 
leptin levels (r = 0.784, P<0.001).27,28 Other ones suggested 
that serum leptin levels correlate highly with percentage 
of body fat, increasing exponentially with increasing 
BMI.15,16,21,26,29 We did not ﬁnd signiﬁcant relationship 
between serum leptin levels and BMI in control group. 
Females had higher stress levels than males in both 
groups, although the diﬀerence was not signiﬁcant in IBS 
group (Table 3). Other studies reported similar results.30 
Stress levels were higher in normal/underweight individuals 
than overweight/obese ones but the diﬀerence in IBS 
groups was not signiﬁcant. Karelis et al31 found no 
signiﬁcant relationship between stress and BMI. 
We used multivariate logistic regression analysis to 
assess if BMI and stress levels had any confounding eﬀects 
on the relationship between serum leptin levels and IBS. 
BMI was excluded from the model because of nonsigniﬁcant 
diﬀerence. Adjusted odds ratios for serum leptin level and 
stress level were nearly the same as crude ones (Table 4). 
This shows that serum leptin level is signiﬁcantly lower in 
IBS group than controls and this relationship is independent 
of other variables such as stress levels, BMI, etc. 
TABLE 4. Relationship Between BMI, Serum Leptin Level and Stress Level, and Irritable Bowel Syndrome 
Variables IBS Group Control Group Crude Odds Ratio* CI 95% Adjusted Odds Ratio* 95% CI 
BMI (kg/m2) 25.1 ± 4.75 25 ± 4.99 1.05 0.97-1.14 — — 
Serum leptin level (ng/mL) 7.41 ± 6.79 19.33 ± 15.8 0.89 0.84-0.93 0.9 0.85-0.94 
Stress level (PSS) 21.74 ± 6.62 15.31 ± 6.64 1.16 1.09-1.24 1.15 1.09-1.23 
*Multivariate logistic regression analysis.
 
BMI indicates body mass index; CI, conﬁdence interval; IBS, irritable bowel syndrome; PSS, Perceived Stress Scale.
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Results from animal experimentation suggest a 2-way 
interaction between leptin and the sympathetic nervous 
system, with leptin causing sympathetic activation and 
conversely, the sympathetic system imposing a feedback 
regulatory inhibitory mechanism over leptin release.32 In 
contrast, down-regulation of neuropeptide Y expression in 
hypothalamus by leptin, results in increased sympathetic 
nervous system outﬂow.33 In addition, leptin modiﬁes the 
activity of the hypothalamo-pituitary axis in the adult 
rodent and inhibits the production of glucocorticoids from 
human and rat adrenals in vitro.18,34 As leptin and cortisol 
show an inverse circadian rhythm, it has been suggested 
that a regulatory feedback mechanism exist between the 2 
hormones.35 Interactions between brain and gut have been 
known as an important underlying pathophysiologic path­
way in IBS.36 Recently, Piche et al37 showed that fatigue 
had a signiﬁcant correlation with serum leptin levels in IBS 
cases. Regarding the above-mentioned facts and also our 
results, it can be concluded that leptin may alter bowel 
movement and consequently play a role in pathomechanism 
of IBS by aﬀecting sympathetic system and adrenal 
catecholamine release. Complementary studies are needed 
to prove this relationship and clearly to determine the role 
of leptin in development of IBS. 
The limitation of this study was due to its design (case­
control). That means we evaluated the relationship between 
IBS, leptin and stress contemporary, so causality could not 
be assessed in this study and more researches are needed to 
clarify the cause-eﬀect relationship in this setting. 
CONCLUSIONS 
This study indicated the relationship between leptin 
and IBS for the ﬁrst time. We found that serum leptin levels 
are signiﬁcantly lower in IBS patients than control group. 
Our ﬁndings may help in better understanding of the 
pathogenesis of IBS and consequently lead to development 
of more eﬀective treatments. 
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